USDA, FDA take steps on hemp CBD. For FDA, this could be a long road.

By Sebastian Krawiec

A road to the Moon. By Diana Salinas-Sandoval

The biggest question mark regarding hemp has been the use of hemp-derived constituents, most notably cannabidiol (CBD), in dietary supplements and food. Currently, CBD is not authorized to be a dietary supplement or used in food because CBD was an Investigational New Drug (IND) and has since been approved as a treatment for epilepsy (via the FDA-approved drug Epidiolex). However, hemp extracts and functional foods with hemp-derived CBD have become a thriving industry, skirting regulation. With the passage of the 2018 Farm Bill, FDA has to come up with a solution to this disparity, and FDA Commissioner Scott Gottlieb acknowledged this much in his recent testimony on February 27 at a hearing of the House Appropriations Committee’s Subcommittee on Agriculture, Rural Development, Food and Drug Administration, and Related Agencies.


Read the whole article here

5/5 (1 Review)